US5670488A
(en)
*
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
US20020164782A1
(en)
|
1999-02-10 |
2002-11-07 |
Gregory Richard J. |
Adenovirus vectors for gene therapy
|
US20020146392A1
(en)
*
|
1993-06-24 |
2002-10-10 |
Frank L. Graham |
Helper dependent adenovirus vectors based on site-specific recombinases
|
US20020136708A1
(en)
*
|
1993-06-24 |
2002-09-26 |
Graham Frank L. |
System for production of helper dependent adenovirus vectors based on use of endonucleases
|
US7045347B2
(en)
|
1993-06-24 |
2006-05-16 |
Advec, Inc. |
Helper dependent adenovirus vectors based on integrase family site-specific recombinases
|
US6730507B1
(en)
|
1993-06-24 |
2004-05-04 |
Merck & Co., Inc. |
Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
|
US6379943B1
(en)
*
|
1999-03-05 |
2002-04-30 |
Merck & Co., Inc. |
High-efficiency Cre/loxp based system for construction of adenovirus vectors
|
JP4216350B2
(ja)
*
|
1994-09-19 |
2009-01-28 |
大日本住友製薬株式会社 |
動物細胞感染用の組換えdnaウイルスベクター
|
US6720140B1
(en)
|
1995-06-07 |
2004-04-13 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
JP4020429B2
(ja)
|
1995-06-07 |
2007-12-12 |
インヴィトロジェン コーポレーション |
操作された組換え部位を使用する組換えクローニング
|
US20060110798A1
(en)
*
|
1995-06-07 |
2006-05-25 |
Graham Frank L |
Cells expressing recombinase useful for adenovirus vector production and control of gene expression
|
US6143557A
(en)
*
|
1995-06-07 |
2000-11-07 |
Life Technologies, Inc. |
Recombination cloning using engineered recombination sites
|
US6964861B1
(en)
*
|
1998-11-13 |
2005-11-15 |
Invitrogen Corporation |
Enhanced in vitro recombinational cloning of using ribosomal proteins
|
DE69633565T3
(de)
*
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
US6265212B1
(en)
|
1995-06-15 |
2001-07-24 |
Introgene B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
US6783980B2
(en)
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
FR2737501B1
(fr)
*
|
1995-07-31 |
1997-10-24 |
Transgene Sa |
Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
|
DE19623203A1
(de)
*
|
1995-11-24 |
1997-05-28 |
Max Planck Gesellschaft |
Virusvektor für den Transfer stabiler Episome
|
US20020193580A1
(en)
*
|
1995-12-15 |
2002-12-19 |
Mitchell Lloyd G. |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
US20030027250A1
(en)
*
|
1995-12-15 |
2003-02-06 |
Mitchell Lloyd G. |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
US20060088938A1
(en)
*
|
1995-12-15 |
2006-04-27 |
Mitchell Lloyd G |
Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants
|
WO1997025446A1
(en)
*
|
1996-01-05 |
1997-07-17 |
Genetic Therapy, Inc. |
Recombinase-mediated generation of adenoviral vectors
|
WO1997032481A1
(en)
*
|
1996-03-07 |
1997-09-12 |
The Regents Of The University Of California |
Helper-free, totally defective adenovirus for gene therapy
|
US6630346B1
(en)
*
|
1996-06-20 |
2003-10-07 |
Merck & Co., Inc. |
Gene therapy for obesity
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
KR20000048820A
(ko)
*
|
1996-10-01 |
2000-07-25 |
게론 코포레이션 |
텔로머라제 역전사 효소
|
US7585622B1
(en)
*
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
US5994132A
(en)
*
|
1996-10-23 |
1999-11-30 |
University Of Michigan |
Adenovirus vectors
|
DE69739351D1
(de)
|
1996-12-16 |
2009-05-20 |
Eisai R&D Man Co Ltd |
DNA-Konstrukt umfassend ein Medikamenten-Resistenzgen und ein fremdes Gen
|
US6403370B1
(en)
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
JP2000509614A
(ja)
*
|
1997-03-04 |
2000-08-02 |
バクスター インターナショナル インコーポレイテッド |
アデノウイルスe1−相補性細胞系
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
AU9319198A
(en)
|
1997-09-19 |
1999-04-05 |
Trustees Of The University Of Pennsylvania, The |
Methods and vector constructs useful for production of recombinant aav
|
US7351578B2
(en)
*
|
1999-12-10 |
2008-04-01 |
Invitrogen Corp. |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
WO1999021977A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Recombinational cloning using nucleic acids having recombination sites
|
AU1539499A
(en)
*
|
1997-11-25 |
1999-06-15 |
Princeton University |
Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
|
DE19807265C2
(de)
*
|
1998-02-20 |
2000-01-05 |
Centeon Pharma Gmbh |
Adenoviraler Transfervektor für den Gentransport einer DNA-Sequenz
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
US6670188B1
(en)
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
WO2000012740A2
(en)
|
1998-08-28 |
2000-03-09 |
Duke University |
ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
|
US6303362B1
(en)
|
1998-11-19 |
2001-10-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adenoviral vector and methods for making and using the same
|
JP2002535986A
(ja)
*
|
1999-02-04 |
2002-10-29 |
メルク エンド カムパニー インコーポレーテッド |
遺伝子治療用の改良ヘルパーディペンデントベクター系
|
EP1157103A2
(de)
*
|
1999-02-18 |
2001-11-28 |
Merck & Co., Inc. |
Herstellung von helferabhängigen adenovirusvektoren unter verwendung von endonucleasen
|
EP2119788A1
(de)
|
1999-03-02 |
2009-11-18 |
Life Technologies Corporation |
Zusammensetzungen und Verfahren zur Verwendung beim Rekombinationsklonen von Nukleinsäuren
|
AU765093B2
(en)
|
1999-03-05 |
2003-09-11 |
Advec, Inc. |
Enhanced system for construction of adenovirus vectors
|
US20030215423A1
(en)
*
|
1999-04-01 |
2003-11-20 |
Merck & Co., Inc. |
Gene therapy for obesity
|
KR100702275B1
(ko)
*
|
1999-04-06 |
2007-03-30 |
위스콘신 얼럼나이 리서어치 화운데이션 |
백신 및 유전자 치료용 재조합 인플루엔자 바이러스
|
EP1165817A1
(de)
*
|
1999-04-06 |
2002-01-02 |
Merck & Co., Inc. |
Verwendung von helferabhängigen adenoviralen vektoren alternativer serotypen zur wiederholten vektorverabreichung
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
CA2721011A1
(en)
|
1999-10-22 |
2001-05-03 |
Aventis Pasteur Limited |
Modified gp100 and uses thereof
|
NZ530816A
(en)
|
1999-12-10 |
2005-10-28 |
Invitrogen Corp |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
US6867022B1
(en)
|
2000-01-21 |
2005-03-15 |
Regents Of The University Of Michigan |
Replication deficient adenovirus vectors and methods of making and using them
|
US7132277B1
(en)
*
|
2000-01-31 |
2006-11-07 |
Merck & Co., Inc. |
Helper dependent vector system for gene therapy
|
AU2001255336B8
(en)
|
2000-04-14 |
2005-10-20 |
Wisconsin Alumni Research Foundation |
Viruses comprising mutation ion channel protein
|
CA2408328C
(en)
*
|
2000-05-10 |
2012-04-17 |
Aventis Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
US7244560B2
(en)
*
|
2000-05-21 |
2007-07-17 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
AU2001280576A1
(en)
*
|
2000-07-18 |
2002-01-30 |
Uab Research Foundation |
Tissue-specific self-inactivating gene therapy vector
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
AU2001288839A1
(en)
*
|
2000-09-08 |
2002-03-22 |
The General Hospital Corporation |
Self-rearranging dna vectors
|
US7820441B2
(en)
|
2000-09-25 |
2010-10-26 |
The Regents Of The University Of Michigan |
Production of viral vectors
|
WO2002041922A1
(fr)
*
|
2000-11-24 |
2002-05-30 |
Chugai Seiyaku Kabushiki Kaisha |
Procede servant a reguler l'activite de l'expression d'un produit genetique transfere dans un organisme vivant
|
US20040126774A1
(en)
*
|
2001-01-08 |
2004-07-01 |
Mitchell Lioyd G. |
Correction of factor VIII genetic defects using spliceosome mediated RNA trans splicing
|
JP2004532039A
(ja)
*
|
2001-03-26 |
2004-10-21 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
ヘルパー依存性アデノウイルスベクター系およびその系の使用方法
|
WO2002086144A2
(en)
*
|
2001-04-19 |
2002-10-31 |
Invitrogen Corporation |
Compositions and methods for recombinational cloning of nucleic acid molecules
|
EP1451344A4
(de)
*
|
2001-05-21 |
2005-03-23 |
Invitrogen Corp |
Zusammensetzungen und verfahren zur verwendung bei der isolierung von nukleinsäuremolekülen
|
WO2003002735A2
(en)
*
|
2001-06-28 |
2003-01-09 |
Phenogene Therapeutiques Inc. |
Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature
|
EP1427816A4
(de)
|
2001-09-18 |
2004-12-01 |
Clontech Lab Inc |
Auf stellenspezifischer rekombinase beruhendes verfahren zur herstellung von adenovirusvektoren
|
EP1516055A4
(de)
*
|
2002-01-24 |
2007-08-08 |
Scripps Research Inst |
Faserschaftmodifikationen für effizientes zielen
|
US7399753B2
(en)
*
|
2002-02-25 |
2008-07-15 |
Virxsys Corporation |
Trans-splicing mediated photodynamic therapy
|
AU2003223527B2
(en)
|
2002-04-09 |
2009-01-15 |
Sanofi Pasteur Limited |
Modified CEA nucleic acid and expression vectors
|
WO2004050680A2
(en)
*
|
2002-05-08 |
2004-06-17 |
Intronn, Inc. |
Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
MXPA05003225A
(es)
*
|
2002-09-27 |
2005-07-05 |
Powderject Res Ltd |
Construcciones de acido nucleico para la expresion genica.
|
ATE471387T1
(de)
*
|
2002-10-23 |
2010-07-15 |
Virxsys Corp |
Screening-verfahren zur identifizierung wirksamer prä-trans-spleissmoleküle
|
US20040203133A1
(en)
*
|
2003-01-07 |
2004-10-14 |
Anja Ehrhardt |
Helper dependent adenoviral vector system and methods for using the same
|
RU2351651C2
(ru)
|
2003-04-23 |
2009-04-10 |
Висконсин Эламни Рисеч Фаундэйшн |
Выделенный рекомбинантный вирус гриппа и способы его получения
|
EP1644538A4
(de)
*
|
2003-06-26 |
2006-11-08 |
Invitrogen Corp |
Verfahren und zusammensetzungen zum nachweis von promotoraktivität und zur expression von fusionsproteinen
|
KR101162970B1
(ko)
*
|
2003-10-08 |
2012-07-12 |
테리온 바이오로직스, 인크. |
변형된 cea/b7 벡터
|
EP2287341B1
(de)
|
2003-12-01 |
2013-02-13 |
Life Technologies Corporation |
Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon
|
CA2553828A1
(en)
*
|
2004-01-23 |
2005-08-04 |
Intronn, Inc. |
Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
|
WO2005070948A1
(en)
*
|
2004-01-23 |
2005-08-04 |
Intronn, Inc. |
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing
|
US7968334B2
(en)
*
|
2004-01-23 |
2011-06-28 |
Virxsys Corporation |
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
|
US20060094110A1
(en)
*
|
2004-07-30 |
2006-05-04 |
Mcgarrity Gerard J |
Use of spliceosome mediated RNA trans-splicing for immunotherapy
|
US20060134658A1
(en)
*
|
2004-08-09 |
2006-06-22 |
Garcia-Blanco Mariano A |
Use of RNA trans-splicing for generation of interfering RNA molecules
|
ES2347340T3
(es)
|
2004-09-13 |
2010-10-28 |
Genzyme Corporation |
Construcciones multimericas.
|
DE102004047492B4
(de)
*
|
2004-09-23 |
2006-07-20 |
Jost-Werke Gmbh & Co. Kg |
Verfahren zum Übertragen von elektrischer, pneumatischer oder hydraulischer Energie sowie ein Energieübertragungssystem
|
US7871795B2
(en)
|
2004-10-08 |
2011-01-18 |
Virxsys Corporation |
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
|
US7879321B2
(en)
*
|
2004-10-08 |
2011-02-01 |
Virxsys Corporation |
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
|
JP2008520248A
(ja)
|
2004-11-19 |
2008-06-19 |
ウィスコンシン・アラムナイ・リサーチ・ファウンデイション |
タンデム転写ユニットを有する組換えインフルエンザベクター
|
US20070243617A1
(en)
*
|
2005-10-13 |
2007-10-18 |
Holt Robert A |
Modular genomes for synthetic biology and metabolic engineering
|
AR059089A1
(es)
|
2006-01-20 |
2008-03-12 |
Genzyme Corp |
Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
|
PT1988823T
(pt)
|
2006-02-09 |
2018-11-22 |
Genzyme Corp |
Administração intraventricular lenta
|
CA2647985C
(en)
|
2006-03-31 |
2014-12-30 |
Warf-Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
ES2337973B8
(es)
*
|
2008-05-16 |
2011-07-21 |
Proyecto De Biomedicina Cima, S.L. |
Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
|
EP2493912B1
(de)
|
2009-10-26 |
2020-07-29 |
Wisconsin Alumni Research Foundation |
Rekombinante influenzaviren mit hohem titer und erhöhter replikation in vero-zellen
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
US9821114B2
(en)
|
2012-02-07 |
2017-11-21 |
Global Bio Therapeutics, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
WO2015009743A1
(en)
|
2013-07-15 |
2015-01-22 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
CN105813579B
(zh)
|
2013-08-08 |
2019-05-07 |
全球生物疗法有限公司 |
用于微创手术过程的夹具装置和其应用
|
EP3564379A1
(de)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selektive rückgewinnung
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
SG11201804713VA
(en)
|
2015-12-11 |
2018-07-30 |
California Inst Of Techn |
TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
EP3612202A2
(de)
|
2017-04-21 |
2020-02-26 |
Baylor College of Medicine |
Onkolytische virotherapie und immuntherapie
|
WO2020068990A1
(en)
|
2018-09-26 |
2020-04-02 |
California Institute Of Technology |
Adeno-associated virus compositions for targeted gene therapy
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
EP4060028A4
(de)
*
|
2019-10-23 |
2023-10-04 |
Genenmed Co., Ltd. |
Auf helferplasmiden basierendes system zur produktion von gutless-adenoviren
|
IL296417A
(en)
|
2020-03-15 |
2022-11-01 |
Proteinea Inc |
Production of recombinant proteins in insects
|
WO2023017494A1
(en)
|
2021-08-13 |
2023-02-16 |
Triovance Holding Llc |
A skin substitute composition and methods of producing and using the same
|
CN114410683B
(zh)
*
|
2022-01-12 |
2023-11-28 |
中国人民解放军空军军医大学 |
一种基于Cre-lox重组系统的RIM3-RNAi及其应用
|
CN114369623B
(zh)
*
|
2022-01-12 |
2023-07-07 |
中国人民解放军空军军医大学 |
一种基于Cre-lox重组系统的Synaptotagmin2-RNAi及其应用
|